Sarepta therapeutics announces fourth quarter and full-year 2020 financial results and recent corporate developments

– net product sales for the fourth quarter and full-year 2020 of $122.6 million and $455.9 million, respectively, were pre-announced in january 2021 at the j.p. morgan healthcare conference –

SRPT Ratings Summary

SRPT Quant Ranking